Gianni is a Partner with Versant Ventures. Gianni previously served as a Senior Executive with several pharmaceutical companies, most recently Hoffmann-La Roche, where he successfully lead research and development teams. Gianni’s roles at Roche included Research Head of Global Cardiovascular and Metabolic Research, where he was responsible for all discovery and development activities in the CV, Renal and Metabolic areas; Head of Discovery Research, Basel Site; Global Head of the Metabolic and Vascular Disease Business Unit; and more recently Head of the Roche China R&D center, Shanghai. Prior to Roche, Gianni was Assistant Professor (tenure track), Immunobiology Research Center, Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA; Research Director at Italfarmaco SpA, Milano, Italy; and Director of Biology-Cardiovascular-Lilly Research Laboratories, Indianapolis, Indiana, USA.
He served as a Scientific Advisor to CSIRO (Australia), Baker Institute (Australia), Integra (Yissum/ Hebrew University, Israel) Momentum Fund (Ramot / Tel Aviv University).
He serves on the Board of Directors of Novira Therapeutics (USA), and Piqur (Switzerland).
Gianni received his MD and PhD in Clinical and Experimental Hematology at University of Milano, Italy.